- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Japan Breast Cancer Research Group (JBCRG)
Total 149 results
-
PfizerJapan Breast Cancer Research Group (JBCRG)Completed
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Japan Breast Cancer Research NetworkCompleted
-
Japan Breast Cancer Research NetworkTerminatedBreast NeoplasmsJapan
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
SOLTI Breast Cancer Research GroupTerminated
-
Spanish Breast Cancer Research GroupActive, not recruitingMetastatic Breast CancerSpain
-
Spanish Breast Cancer Research GroupCompleted
-
SOLTI Breast Cancer Research GroupCompleted
-
SOLTI Breast Cancer Research GroupNot yet recruitingBreast Cancer Stage IVSpain
-
SOLTI Breast Cancer Research GroupRecruitingBreast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast CancerSpain
-
Spanish Breast Cancer Research GroupRecruiting
-
SOLTI Breast Cancer Research GroupCompletedMetastatic Breast CancerSpain
-
SOLTI Breast Cancer Research GroupTerminated
-
SOLTI Breast Cancer Research GroupCompleted
-
SOLTI Breast Cancer Research GroupCompleted
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Genentech, Inc.Breast International Group; SOLTI Breast Cancer Research Group; Austrian Breast...CompletedBreast CancerUnited States, United Kingdom, Germany, Australia, Austria, Belgium, Brazil, France, Guatemala, Italy, Korea, Republic of, Panama, Poland, Portugal, Spain, Czechia, Hungary, Mexico, Peru, Switzerland, El Salvador, Chile
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; German Breast GroupCompletedBreast CancerSpain, Germany
-
Novartis PharmaceuticalsBreast International Group; SOLTI Breast Cancer Research GroupCompletedNeoplasms, BreastFrance, Spain, United Kingdom, Belgium, Argentina, Czechia, Germany, Italy, Norway, Russian Federation, Sweden, Taiwan, Hong Kong, Brazil, Hungary, India, Korea, Republic of, Pakistan, Peru, Romania, South Africa, Ukraine, Canada, Lit...
-
Spanish Breast Cancer Research GroupSanofiCompleted
-
Spanish Breast Cancer Research GroupNovartisCompleted
-
Spanish Breast Cancer Research GroupNovartisCompletedBreast Cancer | Neoplasm MetastasisSpain
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
Spanish Breast Cancer Research GroupAstraZenecaActive, not recruitingBreast NeoplasmsSpain, Ireland
-
Spanish Breast Cancer Research GroupSanofiCompleted
-
Spanish Breast Cancer Research GroupAstraZenecaRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerSpain
-
SOLTI Breast Cancer Research GroupNovartisRecruitingMelanoma | Sarcoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Uterine Carcinosarcoma | Mesothelioma | Cholangiocarcinoma | Lung Adenocarcinoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal... and other conditionsSpain
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
Spanish Breast Cancer Research GroupGlaxoSmithKlineCompleted
-
Spanish Breast Cancer Research GroupCelgeneCompleted
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Spanish Breast Cancer Research GroupAstraZenecaTerminated
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Spanish Breast Cancer Research GroupNovartisTerminatedBreast Cancer | Neoplasm MetastasisSpain
-
SanofiSOLTI Breast Cancer Research GroupCompletedBreast Cancer FemaleSpain, France, Germany
-
SOLTI Breast Cancer Research GroupNovartis; UNICANCERRecruitingBreast Cancer Stage IISpain, France, Portugal
-
SOLTI Breast Cancer Research GroupEisai Inc.CompletedBreast CancerSpain, France, Portugal, Germany
-
SOLTI Breast Cancer Research GroupSchering-PloughCompleted
-
Cantargia ABSpanish Breast Cancer Research GroupRecruitingTriple Negative Breast CancerSpain
-
Spanish Breast Cancer Research GroupSchering-PloughCompletedBreast CancerSpain
-
Spanish Breast Cancer Research GroupNovartis PharmaceuticalsCompletedBreast Carcinoma Metastatic to the BoneSpain
-
Spanish Breast Cancer Research GroupSchering-PloughCompleted
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
Spanish Breast Cancer Research GroupSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Locally Advanced HER2 Positive Breast CarcinomaSpain